EXCITATORY AMINO-ACID ANTAGONISTS PROTECT MICE AGAINST SEIZURES INDUCED BY BICUCULLINE

被引:50
作者
TURSKI, WA [1 ]
URBANSKA, E [1 ]
DZIKI, M [1 ]
PARADATURSKA, J [1 ]
IKONOMIDOU, C [1 ]
机构
[1] FREE UNIV BERLIN,CLIN RUDOLF VIRCHOW CHARLOTTENBURG,DEPT PEDIAT NEUROL,W-1000 BERLIN 33,GERMANY
关键词
Antagonist; Bicuculline; Kainate; Muscimol; N-methyl-d-aspartate; Quisqualate; Seizure; γ-Aminobutyric acid;
D O I
10.1016/0006-8993(90)90444-G
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of excitatory amino acid antagonists on convulsions induced by intracerebroventricular (i.c.v.) or systemic (s.c.) administration of the γ-aminobutyric acidA (GABAA) antagonist bicuculline (BIC) were tested in mice. 3-((±)-2-Carboxypiperazin-4-yl)-propyl-1-phosphonate (CPP), 2-amino-7-phosphonoheptanoate (AP7) and (+)-5-methyl-10,11-dihydro-5H-dibenzo(a,d)cycloheptan-5,10-imine maleate (MK-801) were used as representatives of N-methyl-d-aspartate (NMDA) antagonists. γ-d-Glutamylaminomethylsulphonate (γ-d-GAMS) typified a preferential kainate (KA) antagonist, 6-cyano-7-nitro-quinoxaline-2,3-dione (CNQX) represented a preferential quisqualate (QA) antagonist, and kynurenic acid (KYNA) was used as a mixed NMDA/KA antagonist. Bicuculline methiodide (BMI) induced clonic convulsions following i.c.v. administration with a CD50 of 0.183 nmol (range 0.164-0.204). The excitatory amino acid antagonists blocked clonic seizures induced by BMI in the dose of 0.224 nmol (approximately CD97) when coinjected into the lateral ventricle. CPP (ED50 0.0075 nmol) was the most potent anticonvulsant and was followed by AP7 (0.182 nmol), MK-801 (0.22 nmol), γ-d-GAMS (0.4 nmol), KYNA (1.7 nmol) and CNQX (5.17 nmol). Muscimol (MSC), the GABAA agonist, blocked BMI-induced seizures with an ED50 0.25 nmol. Systemic (s.c.) administration of BIC induced in mice generalized seizures with a CD50 of 2.2 mg/kg (range 1.9-2.5) for clonus and CD50 of 2.4 mg/kg (range 2.2-2.7) for tonus. The seizures induced by s.c. injection of BIC in the dose of 3.2 mg/kg (approximately CD97) were blocked by pretreatment (i.p.) with the NMDA antagonists MK-801 (ED50 0.075 mg/kg for clonus and 0.044 mg/kg for tonus), CPP (7.743 mg/kg for clonus and 0.032 mg/kg for tonus) and CGS 19755 (> 10 mg/kg for clonus and 3.01 mg/kg for tonus). GABAA agonist MSC had no effect on clonus (> 2.5 mg/kg) and prevented mice from tonus with an ED50 of 1.77 mg/kg. These results suggest an important role of excitation mediated by dicarboxylic amino acids in the pathogenesis of seizures triggered by bicuculline in mice. © 1990.
引用
收藏
页码:131 / 134
页数:4
相关论文
共 16 条
[1]   AN N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTAGONIST REDUCES BICUCULLINE-INDUCED DEPOLARIZATION SHIFTS IN NEOCORTICAL EXPLANT CULTURES [J].
BALDINO, F ;
WOLFSON, B ;
HEINEMANN, U ;
GUTNICK, MJ .
NEUROSCIENCE LETTERS, 1986, 70 (01) :101-105
[2]  
CHAPMAN AG, 1988, FRONTIERS EXCITATORY, P203
[3]  
ENGEL J, 1987, EPILEPTIC FOCUS, P83
[4]   QUINOXALINEDIONES - POTENT COMPETITIVE NON-NMDA GLUTAMATE RECEPTOR ANTAGONISTS [J].
HONORE, T ;
DAVIES, SN ;
DREJER, J ;
FLETCHER, EJ ;
JACOBSEN, P ;
LODGE, D ;
NIELSEN, FE .
SCIENCE, 1988, 241 (4866) :701-703
[5]   SPONTANEOUS PAROXYSMAL ACTIVITY INDUCED BY ZERO MAGNESIUM AND BICUCULLINE - SUPPRESSION BY NMDA ANTAGONISTS AND GABA MIMETICS [J].
HORNE, AL ;
HARRISON, NL ;
TURNER, JP ;
SIMMONDS, MA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 122 (02) :231-238
[6]   NMDA RECEPTOR ANTAGONISTS CPP AND MK-801 PARTIALLY SUPPRESS THE EPILEPTIFORM DISCHARGES INDUCED BY THE CONVULSANT DRUG BICUCULLINE IN THE RAT NEOCORTEX [J].
HWA, GGC ;
AVOLI, M .
NEUROSCIENCE LETTERS, 1989, 98 (02) :189-193
[8]   PHARMACOLOGY OF GABA [J].
MELDRUM, B .
CLINICAL NEUROPHARMACOLOGY, 1982, 5 (03) :293-316
[10]  
MELDRUM B, 1984, PSYCHOPHARMACOLOGY L, P89